Nuvalent, Inc.
NUVL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $84 | $81 | $74 | $69 |
| G&A Expenses | $29 | $24 | $20 | $17 |
| SG&A Expenses | $29 | $24 | $20 | $17 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $113 | $105 | $95 | $86 |
| Operating Income | -$113 | -$105 | -$95 | -$86 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$10 | $5 | $10 | $12 |
| Pre-Tax Income | -$122 | -$100 | -$84 | -$75 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$122 | -$100 | -$85 | -$75 |
| % Margin | – | – | – | – |
| EPS | -1.7 | -1.39 | -1.18 | -1.05 |
| % Growth | -22.3% | -17.8% | -12.4% | – |
| EPS Diluted | -1.7 | -1.39 | -1.18 | -1.05 |
| Weighted Avg Shares Out | 72 | 72 | 72 | 71 |
| Weighted Avg Shares Out Dil | 72 | 72 | 72 | 71 |
| Supplemental Information | – | – | – | – |
| Interest Income | $10 | $11 | $12 | $13 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$122 | -$105 | -$95 | -$86 |
| % Margin | – | – | – | – |